Skip to main content
Clinical Trials/NCT04546971
NCT04546971
Active, not recruiting
Not Applicable

Using Telehealth to Address Alcohol Misuse in HIV Care

Brown University1 site in 1 country600 target enrollmentJune 22, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Alcohol Drinking
Sponsor
Brown University
Enrollment
600
Locations
1
Primary Endpoint
Proportion of participants with a detectable HIV viral load
Status
Active, not recruiting
Last Updated
8 months ago

Overview

Brief Summary

This project will test the effects of a telehealth counseling program on reducing alcohol use and improving HIV viral control among people with HIV who drink heavily. In total, 600 heavy drinkers with HIV will be assigned to either (a) a single session of brief counseling on alcohol use or (b) brief counseling plus referral to a telehealth counseling program that includes multiple sessions of counseling by videoconferencing and text messaging support. To understand the effects of the program, participants' alcohol use, HIV outcomes, and health will be assessed over a 2-year period.

Detailed Description

The purpose of the proposed study is to test the real-world effectiveness of the ReACH (Reducing Alcohol use and related Comorbidities in HIV care) telehealth counseling protocol in a pragmatic Hybrid Type 1 effectiveness-implementation randomized trial. The study will recruit 600 heavy-drinking PLWH from four federally-qualified health centers in geographically distinct regions across the U.S, which provide services to over 14,000 PLWH. Upon completing enrollment, participants will be randomized to receive either single-session brief intervention (BI) by phone with referral to local treatment when appropriate or BI plus referral to ReACH telehealth counseling (TC). Participants will complete follow-ups through 24 months after baseline to assess longer-term changes in drinking and health outcomes. The study will test the hypothesis that TC compared to BI will result in (a) reduced number of drinks consumed per week and frequency of heavy drinking and (b) increased odds of having an undetectable viral load at 12- and 24-month follow-ups. Secondary outcomes include self-reported ART adherence, engagement in condomless sex with non-exclusive partners, frequency of other substance use, phosphatidylethanol levels (a biomarker of recent alcohol use), and Veterans Aging Cohort Study index scores. The study also will examine potential moderators of TC effectiveness. As a secondary aim, implementation measures corresponding to aspects of the Dynamic Sustainability Framework will be assessed including implementation outcomes of acceptability, appropriateness, and feasibility guided by Proctor's Implementation Outcomes Framework. Thus, this pragmatic Hybrid Type 1 trial will help establish the real-world effectiveness of the ReACH TC intervention while also providing key implementation-related measures and outcomes that will inform future ReACH TC scale up and sustainability.

Registry
clinicaltrials.gov
Start Date
June 22, 2021
End Date
May 15, 2026
Last Updated
8 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Christopher W. Kahler

Professor

Brown University

Eligibility Criteria

Inclusion Criteria

  • In care for HIV at one of 4 participating federally qualified health centers, report at least one heavy drinking day (4+ drinks) or average more than 7 drinks per week in the past 30 days

Exclusion Criteria

  • need for supervised alcohol detoxification, as indicated by having a history of severe withdrawal symptoms such as seizures and delirium tremens.

Outcomes

Primary Outcomes

Proportion of participants with a detectable HIV viral load

Time Frame: 24 months

Viral load test result that indicates HIV virus is detectable in the blood

Alcoholics drinks consumed per week

Time Frame: 24 months

Average number of alcoholic drinks consumed per week over the past 30 days

Number of heavy drinking days

Time Frame: 24 months

Number of days consuming 4 or more drinks in a day over the past 30 days

Secondary Outcomes

  • Condomless sex with non-steady partners(24 months)
  • Proportion of the past 30 days adherent to antiretroviral therapy(24 months)
  • Veterans Aging Cohort Study (VACS) index total score(24 months)

Study Sites (1)

Loading locations...

Similar Trials